MedTrace Logo

Efficacy of Acupuncture in Macular Diseases

NCT02255981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-06-16

Study results available
· View outcomes & findings →

Summary

This is a single-arm study designed to assess the efficacy of acupuncture (Traditional Chinese Medicine) for chronic macular diseases of several types. All participants received acupuncture and massage and there is not a placebo group because it is not considered a good form to evaluate in Chinese Medicine due to, acupuncturing being a procedure is not as blind as is desired. As a control of the results in this trial, the outcomes could be contrasted against those reported in known medical publications and against expectations of the progress of the damage without treatment.

Conditions

Interventions

OTHER

Acupuncture and massage

Treatment consists in to put needles on specific points of skin one day each week initially, then with longer spaces of time according to improvement.A total of 11 Chinese needles stainless steel, 25 x 40 were used by manual insertion and left for 12-15 minutes. Periocular massage is taught and is practiced daily by the patient him or herself.

Sponsors & Collaborators

  • Escuela Neijing

    lead OTHER

Principal Investigators

  • Luz H Gutierrez, MD, MPH · Escuela Neijing Colombia

  • Jose L Padilla, MD · Hispano American Acupuncture Association-Beijing 84, Madrid, Spain

  • José R Gutiérrez, MD, Opht · Sociedad Colombiana de Oftalmología

  • Libia V Ferrer, Tech TCM · Escuela Neijing Colombia

  • Sergio L Pineda · Escuela Neijing Colombia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-05-31
Completion
2016-11-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02255981 on ClinicalTrials.gov